
Slolog 5mg Tablet
Marketer
Renspur Health Care Private Limited
Salt Composition
Solifenacin (5mg)
Overview Slolog 5mg Tablet
Urispas 5mg tablets, a muscarinic receptor blocker, effectively manage overactive bladder symptoms. This medication alleviates urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and regimen. It can be administered with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal therapeutic benefit. Potential side effects include xerostomia, bowel irregularity, nausea, and urinary tract infection. Increased water intake may mitigate these effects. Drowsiness or visual disturbances may occur; avoid driving if affected. Prior to commencing treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require careful monitoring and regular follow-up appointments as directed by their doctor.
Primary Ingredients of Slolog 5mg Tablet
No information provided. A rewrite is impossible.
Uses of Slolog 5mg Tablet
Managing overactive bladder (OAB) symptoms
Major Benefits of Slolog 5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Slolog 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Slolog 5mg Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Nausea
- Upset stomach
- Urinary tract infection
How to use Slolog 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Slolog 5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Slolog 5mg Tablet works:
Urinary incontinence can be managed with Slolog 5mg tablets, an antimuscarinic agent. These tablets reduce bladder muscle spasms, thereby lessening the frequency, urgency, and involuntary release of urine.
SAFETY ADVICE
AlcoholCAUTION
Use of Slolog 5mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Slolog 5mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Slolog 5mg tablets while breastfeeding is likely safe. Available data from human studies indicate minimal risk to the infant. However, prolonged use of Slolog 5mg tablets may decrease milk supply and potentially lead to constipation, dry mouth, and urinary tract infections in the baby.
DrivingUNSAFE
Driving ability may be impaired by Slolog 5mg Tablet, which can induce side effects such as blurred vision, drowsiness, and fatigue.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Slolog 5mg tablets, as dose modification may be necessary. Dialysis patients should avoid Slolog 5mg tablets. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Slolog 5mg tablets, potentially requiring dosage modification. A physician's consultation is advised. Slolog 5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Slolog 5mg Tablet :
Should you forget a Slolog 5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Slolog 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Tetrahydroisoquinoline-Quinuclidine Hybrid |
| Developing Habits | No. |
| Type of Therapy | Urological Care |
| Action Class | Selective M3 muscarinic receptor antagonist (bladder) |
